Published by Josh White on 18th May 2022
(Sharecast News) - Specialist contract research organisation Open Orphan announced on Wednesday that its hVIVO subsidiary has signed a £7.3m flu human challenge study contract with an unnamed biotechnology company, to test its antiviral product using hVIVO's influenza human challenge study model.
URL: http://www.digitallook.com/dl/news/story/32687330/...